Drug intelligence / Profile preview

FARVAC AE

Development stage
Unknown
Lead developer
FARVET
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

FARVAC AE is a live attenuated viral vaccine developed by FARVET for the prevention of Avian Encephalomyelitis (AE) in poultry. The vaccine targets the Avian Encephalomyelitis Virus (AEV), a picornavirus that causes significant neurological disease in young chicks and a drop in egg production in adult layers. By utilizing a live attenuated strain of the virus, the vaccine stimulates a robust and long-lasting immune response, including both humoral and cellular components. It is primarily indicated for use in breeders and commercial layers prior to the onset of egg production to provide active immunity to the birds and passive immunity to their progeny via maternal antibodies. The vaccine is typically administered via drinking water or other mass-application methods common in poultry management.

Brand names
FARVAC AE
Other names
Avian Encephalomyelitis Virus VaccineAEV Vaccine

Beyond the preview

Go deeper on FARVAC AE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FARVAC AE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call